NFKB1 −94ins/delATTG polymorphism is a novel prognostic marker in first line‐treated multiple m
NFKB1 −94ins/delATTG polymorphism is a novel prognostic marker in first line‐treated multiple myeloma - Varga - 2015 - British Journal of Haematology - Wiley Online Library
PDF) The Functional Variations of NFKB1 and NFKB1A in inflammatory disorders and Therapeutic Approaches
Cancers | Free Full-Text | Targeting NF-κB Signaling for Multiple Myeloma
Lamin A/C increases NF-κB activity via nuclear translocation of... | Download Scientific Diagram
Cells | Free Full-Text | Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications
Full article: RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma
NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53 | Modern Pathology
NFKB1 gene rs28362491 ins/del variation is associated with higher susceptibility to myocardial infarction in a Chinese Han population | Scientific Reports
Genotype and allele frequencies of the NFKB1 promoter -94 ins/del ATTG... | Download Table
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy | Journal of Medicinal Chemistry
Polymorphism of CD14 Gene Is Associated with Adverse Outcome among Patients Suffering from Cardiovascular Disease
Cancers | Free Full-Text | A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells
Oficina Española de Patentes y Marcas - Technological information
NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer | Experimental oncology
Development of Novel Cancer Biomarkers for Diagnosis and Prognosis | SpringerLink
Biomedicines | Free Full-Text | NF-κB in Gastric Cancer Development and Therapy
Review NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases
NFKB1 polymorphisms influenced protein expression in plasmid... | Download Scientific Diagram
Full article: Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine
Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner - ScienceDirect
The roles of long non-coding RNAs in lung cancer
